Dose modifications of ribociclib and endocrine therapy for treatment of ER+ HER2− metastatic breast cancer
Kristoffer B. Kristensen, Ida Marie Nedergaard Thomsen, Tobias Berg, Annette Raskov Kodahl, Anders Bonde Jensen
Topics & Concepts
MedicineMetastatic breast cancerBreast cancerEndocrine systemOncologyCancerInternal medicineGynecologyHormoneAdvanced Breast Cancer TherapiesHER2/EGFR in Cancer ResearchEstrogen and related hormone effects